Valeant Pharmaceuticals International Business Analyst Salaries in Wilmington, DE
The average Valeant Pharmaceuticals International Business Analyst in Wilmington, DE earns an estimated $96,998 annually, which includes an estimated base salary of $90,023 with a $6,975 bonus. Valeant Pharmaceuticals International's Business Analyst compensation is $13,527 more than the US average for a Business Analyst. Business Analyst salaries at Valeant Pharmaceuticals International in Wilmington, DE can range from $81,200 - $123,200.
In Wilmington, DE, The Marketing Department at Valeant Pharmaceuticals International earns $2,768 more on average than the Sales Department.
Last updated 2 years ago.
- $90,023
- avg. base
- $6,975
- avg. bonus
Business Analyst Salaries at Valeant Pharmaceuticals International
In Wilmington, DE, Business Analysts earn $140 more than Business Analysts, and $5,188 less than Content Strategists.
Compensation at Valeant Pharmaceuticals International by Department
In Wilmington, DE, The Marketing Department averages $2,768 more than the Sales Department, and $871 less than the Business Development Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $89,933, while the average male Business Analyst at similar sized companies reported making $93,781.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $115,000, while the average African American/Black Business Analyst at similar sized companies reported making $75,705.
How Business Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Business Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Business Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
